Consolidated Balance Sheet

Chiome Bioscience Inc. - Filing #7312329

Concept As at
2024-06-30
As at
2023-12-31
Consolidated balance sheet
Balance sheet
Assets
Non-current assets
136,034,000 JPY
122,058,000 JPY
Investments and other assets
135,454,000 JPY
120,892,000 JPY
Long-term prepaid expenses
22,643,000 JPY
8,081,000 JPY
Other
0 JPY
0 JPY
Current assets
Cash and deposits
1,103,656,000 JPY
1,325,554,000 JPY
Accounts receivable - trade
50,693,000 JPY
83,193,000 JPY
Work in process
5,397,000 JPY
1,644,000 JPY
Inventories
52,443,000 JPY
64,107,000 JPY
Other
92,379,000 JPY
44,695,000 JPY
Advance payments to suppliers
106,909,000 JPY
86,797,000 JPY
Current assets
1,421,405,000 JPY
1,629,396,000 JPY
Non-current assets
Property, plant and equipment
Property, plant and equipment
579,000 JPY
1,166,000 JPY
Investments and other assets
Assets
1,557,439,000 JPY
1,751,454,000 JPY
Liabilities
Current liabilities
Short-term borrowings
292,100,000 JPY
291,000,000 JPY
Deposits received
8,187,000 JPY
5,880,000 JPY
Income taxes payable
11,357,000 JPY
23,952,000 JPY
Accounts payable - other
63,872,000 JPY
116,952,000 JPY
Provisions
Provision for bonuses
JPY
6,730,000 JPY
Accrued expenses
24,369,000 JPY
25,587,000 JPY
Advances received
9,100,000 JPY
31,200,000 JPY
Current liabilities
432,001,000 JPY
539,038,000 JPY
Non-current liabilities
Non-current liabilities
54,906,000 JPY
54,692,000 JPY
Asset retirement obligations
54,906,000 JPY
54,692,000 JPY
Liabilities
486,908,000 JPY
593,731,000 JPY
Liabilities and net assets
Shareholders' equity
1,059,018,000 JPY
1,139,981,000 JPY
Share capital
341,497,000 JPY
2,388,422,000 JPY
Capital surplus
1,281,771,000 JPY
3,988,202,000 JPY
Retained earnings
-563,958,000 JPY
-5,236,350,000 JPY
Treasury shares
-292,000 JPY
-292,000 JPY
Share acquisition rights
11,513,000 JPY
17,741,000 JPY
Net assets
1,070,531,000 JPY
1,157,723,000 JPY
Liabilities and net assets
1,557,439,000 JPY
1,751,454,000 JPY
Net assets
Shareholders' equity

Talk to a Data Expert

Have a question? We'll get back to you promptly.